Anticoagulation Strategies in Non-Critically Ill Patients with Covid-19.
Journal
NEJM evidence
ISSN: 2766-5526
Titre abrégé: NEJM Evid
Pays: United States
ID NLM: 9918317485806676
Informations de publication
Date de publication:
Feb 2023
Feb 2023
Historique:
medline:
6
2
2024
pubmed:
6
2
2024
entrez:
6
2
2024
Statut:
ppublish
Résumé
Anticoagulation in Non-Critically Ill Covid-19 PatientsMcQuilten et al. conducted a randomized clinical trial comparing low-dose, intermediate-dose, low-dose plus aspirin, and therapeutic-dose anticoagulation in patients with Covid-19 of diverse ethnicities in high-, low-, and middle-income countries.
Identifiants
pubmed: 38320033
doi: 10.1056/EVIDoa2200293
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM